Close
Show
Home News Page 226

News

This section brings in the latest news and the headlines in the Pharmaceutical industry. Our dedicated news team closely observes the Pharma Industry and keeps you updated of latest developments across the world.

Lilly’s tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes


Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type...

Merck Expands Life Science Production Capacities in the United States


Merck, a leading science and technology company, announced the broadening of its manufacturing footprint with...
Aizon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing

Aizon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies...


Based on its recent analysis of the North American artificial intelligence (AI) market for productivity...

CluePoints Opens New AsiaPac Office in Tokyo


CluePoints, the premier provider of Central Statistical Monitoring, Risk-Based Quality Management and Data Quality Oversight...

Piramal Pharma Solutions invests US$ 32 mn to expand Michigan facility


Piramal Pharma Limited’s pharma solutions business, a leading contract development and manufacturing organization (CDMO), is...

U.S. FDA confirms Pfizer COVID vaccine safe & effective


The FDA 53-page briefing document gives a green signal to Pfizer-BioNTech COVID-19 vaccine. A US...
UK Begins The Biggest Immunization Program In Its History

UK Begins The Biggest Immunization Program In Its History


The UK has begun immunizing citizens against Coronavirus. Population above 80, the most vulnerable...
Russia Begins Sputnik V Coronavirus Vaccine Distribution

Russia Begins Sputnik V Coronavirus Vaccine Distribution


Sputnik V has been rolled out in Moscow and will be subsequently distributed across...
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19

KaliVir Immunotherapeutics, Astellas ink research agreement to develop and commercialise VET2-L2 novel oncolytic virus


KaliVir Immunotherapeutics LLC and Astellas Pharma Inc announced that they entered into a worldwide licensing...
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials

Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19


Codex DNA, Inc. announced the release of seven new synthetic SARS-CoV-2 genomes for use in...